저자: 미상 · 외국인
요약 보기
Cathie Wood(ARK Invest)의 최근 신규 편입 종목 7개를 소개하는 영상이다. 결론은 ARK 포트폴리오 신규 편입 종목들의 나열이며, 특정 자산에 대한 가격 방향 예측은 없다. [ARK 배경] ARK Innovation ETF는 2020년 152% 상승해 나스닥(43.6%)을 크게 앞섰다. 캐시 우드의 헤지펀드는 3분기 기준 약 140억 달러 규모로 성장했다. 2020년 수익은 블록체인, 로봇, AI, DNA 시퀀싱 등 혁신 산업의 대형 성공 종목에서 나왔다. [7번 미쉐린] 미쉐린(ML.PA)은 1889년 설립된 타이어 대기업이다. 우주왕복선, WRC, 내구레이스, F1에 타이어를 공급한다. 가이드북, 3스타 레스토랑 등록, 디지털 지도 서비스도 운영한다. 2022년 9월 기준 원자재 장비 사업은 유럽·미국·중국에서 성장했고, 트럭·버스 부문도 중국을 제외하고 성장했다. 부채 45억 유로, 영업이익 49억 유로로 재무 여력이 충분하다. ARK 보유 83,484주(약 180만 달러), 3분기 신규 편입. [6번 HUB Security] HUB Security(HUB.TA)는 2017년 설립된 이스라엘 하드웨어 보안 기업이다. 클라우드·금융용 보안 제품을 판매하며 30여 개국에 고객이 있다. 기밀 컴퓨팅 시장은 TAM 540억 달러로 제시됐다. 포스트 양자 암호와 양자 난수 생성을 활용한다. 스위스 기업과 1,800만 달러 주문, 이스라엘 국방부와 3년 계약(NIS 420만)을 확보했다. 나스닥 상장(티커 HUBC)을 추진 중이며 상장 후 기존 주주 81%, CEO 7% 보유 예정. 2022년 상반기 매출 3,600만 달러, 연간 1억 1,500만 달러 목표, 흑자 전환 목표. ARK 보유 약 210만 달러 규모. [5번 COMPASS Pathways] COMPASS Pathways(CMPS)는 런던 소재 정신질환 치료제 개발사다. COMP360은 치료 저항성 우울증에 효과를 보였고 복합 PTSD 임상 중이다. ARK는 3분기에 38만 8,574주(410만 달러) 매수. Oppenheimer는 목표가를 65달러에서 55달러로 낮췄으나 Outperform 유지. 2022년 2분기 895개 헤지펀드 중 12곳이 보유. [4번 Senti Biosciences] Senti Biosciences(SNTI)는 유전자 치료제 개발사로 백혈병, 암 세포 등을 겨냥한다. Chardan은 목표가 12달러를 제시했다. 최근 매출 136만 달러(전년 대비 72% 성장), 주당순이익 0.86달러. ARK는 3분기 200만 주(450만 달러) 편입. [3번 XPeng] XPeng(XPEV)은 광저우 기반 중국 전기차 업체다. 2022년 9월까지 누적 98,553대 인도, 2021년 연간 대비 75% 증가. 중국 전기차 시장은 2022년 9월 기록적인 67.5만 대 판매를 보였다. ARK는 3분기 510만 달러 매수. Tiger Global이 430만 주 보유. [2번 Moderna] Moderna(MRNA)는 mRNA 기술로 암, 면역, 심장, 감염병 치료제를 개발한다. 메르크와 흑색종 암백신을 공동 개발 중이며 임상 결과는 당분기 발표 예정. ARK는 16만 3,592주(1,900만 달러) 보유. 45개 헤지펀드가 투자. Theleme Partners가 630만 주 보유. [1번 Guardant Health] Guardant Health(GH)는 액체생검, 코로나 검사, 암 진단 서비스를 제공한다. 2022년 8월 Guardant360 액체생검 테스트가 FDA 승인을 받아 Enhertu 치료 대상 폐암 환자를 식별한다. 2022년 6월 매출 4억 달러 기록. ARK는 3분기 54만 2,113주(2,900만 달러) 매수. Viking Global이 440만 주(1억 8,000만 달러) 보유. [면책] 교육 목적이며 투자 자문이 아니다.
다듬은 글
In 2020, the ARK Innovation ETF soared more than 152%, easily outpacing the Nasdaq's sizable return of 43.6%. Cathie’s hedge fund has grown over the years to become one of the biggest names in the sector; as of the third quarter of this year, the portfolio was worth an astounding $14 billion. The massive return for the ARKK fund in 2020 came from large stock success stories in cutting-edge innovation industries, including blockchain, robots, artificial intelligence, and DNA sequencing.
Hence in this video, we'll look at Cathie Wood's most recent stock portfolio's newest additions. No. 7. Compagnie Générale des Établissements Michelin Société en commandite par actions (EPA:ML.PA), Value of Ark Investment's Position: $1.8 Million. One of the biggest tire producers in the world is Compagnie Générale des Établissements Michelin Société en commandite par actions, or simply Michelin.
The company was founded in 1889 and had its headquarters in Clermont-Ferrand, France. It is one of the oldest businesses in the world. The NASA Space Shuttle's tires were made by Compagnie Générale des Établissements Michelin Société en commandite par actions, demonstrating the company's strength in the sector given the demanding specifications for a spacecraft's return from space.
Compagnie Générale des Établissements Michelin Société en commandite par actions also produces tires for the World Rally Championship, endurance racing, and Formula One race vehicles in addition to the Space Shuttle. Compagnie Générale des Établissements Michelin Société en commandite par actions, however, doesn't exclusively work in the tire sector.
The company is also well-known for its tour guides, and the restaurant business highly values its three Michelin Star designation. Additionally, it offers a digital mapping service. According to market data from the company for September 2022, the original equipment business expanded globally, particularly in Europe, America, and China.
The trucks and bus segment of Compagnie Générale des Établissements Michelin Société en commandite par actions has seen growth, and both of these segments have done so globally, with the exception of China. With its most recent debt of EUR 4.5 billion and operating income of EUR 4.9 billion, the company also has a fortress balance sheet, demonstrating that it is more than capable of satisfying all of its obligations.
By the end of the third quarter of this year, Cathie Wood's Ark Investment owned 83,484 shares in Compagnie Générale des Établissements Michelin Société en commandite par actions, valued at $1.8 million. Contrary to Tesla Inc., NVIDIA Corporation, and Zoom Video Communications Inc., which have been part of ARK's portfolio for several quarters, Compagnie Générale des Établissements Michelin Société en commandite par actions is a recent addition to Cathie Wood's portfolio.
No. 6. HUB Security (TLV: HUB.TA), Value of Ark Investment's Position: $2.1 million Israeli startup HUB Security has its main office in Tel Aviv-Yafo. The business creates hardware security products for cloud and financial applications. It was established in 2017 and offered its goods to businesses.
The creators of HUB Security have experience in the Israeli Defense Forces, where they served in the intelligence divisions. The company has clients in more than 30 countries, and its devices are designed to stop hardware-based security invasions and data theft. It also engages in business in the incredibly profitable confidential computing sector, which has a $54 billion total addressable market (TAM) and focuses on products that encrypt data even as it is processed inside a processor or a graphics processing unit.
Furthermore, and perhaps more importantly, the products of HUB Security leverage post-quantum cryptography to deliver safe solutions. In order to accomplish so, key exchange algorithms must be disregarded, removing yet another point of vulnerability for hackers. This is done by leveraging built-in quantum random number generation.
Additionally, HUB Security has an $18 million order from a Swiss company that will enable it to market its secure computing products. Additionally, it was awarded a NIS 4.2 million, three-year contract with the Israeli Defense Ministry. The Securities and Exchange Commission (SEC) has received documents that HUB Security has submitted in order to list its shares on the NASDAQ exchange in a $1.3 billion offering with the ticker HUBC.
Additionally, the company has obtained the critical FIPS 140-2 Level 3 security certification in the United States. After the firm gets listed, its current stockholders will still hold 81% of the company's shares, and its CEO, Mr. Eyal Moshe, will hold 7% of the stock. HUB Security reported $36 million in sales for the first six months of its fiscal year 2022.
By the end of the year, the company hopes to have earned $115 million. Despite recording a loss during the first half of the year, it also aims to become profitable this year. Additionally, this year, HUB Security closed two investment rounds for pipes totalling NIS 64 million. In Cathie Wood's portfolio, HUB is a relatively unheard-of company compared to Tesla Inc., NVIDIA Corporation, and Zoom Video Communications Inc.
No. 5. COMPASS Pathways plc (NASDAQ: CMPS), Value of Ark Investment's Position: $4.1 million The UK's capital city of London serves as the home of the British healthcare organization COMPASS Pathways plc. The company creates treatments for mental illnesses; its COMP360 treatment has successfully treated resilient depression and is presently undergoing trials for the treatment of complex post-traumatic stress disorder.
During the third quarter of this year, Ark Investment purchased 388,574 shares of COMPASS Pathways plc, giving it a $4.1 million holding in the business. According to a Q2 2022 poll by Insider Monkey of 895 hedge funds, 12 of them had also purchased the company's shares. In October 2022, Oppenheimer lowered its price estimate for COMPASS Pathways plc from $65 to $55, citing the uncertainties surrounding filing procedures as a factor in the decision.
The company still rates the stock as Outperform, though. Additionally, seven other therapies for conditions like bipolar disorder, autism, and suicidal thoughts are being funded by COMPASS Pathways plc at several institutions. These educational institutions include the University of Copenhagen, King's College in London, and Columbia University.
According to our database, Christopher Medlock James' Partner Fund Management is the largest shareholder in COMPASS Pathways plc as of the second quarter, holding 392,764 shares worth $4.2 million. No. 4. Senti Biosciences, Inc. (NASDAQ: SNTI), Value of Ark Investment's Position: $4.5 million Gene therapy is developed by Senti Biosciences, Inc., a biotechnology firm.
Leukaemia, carcinoma, and cancer cells are among the illnesses that they target. South San Francisco, California, serves as its administrative centre. In September 2022, Chardan Capital Markets set a $12 share price target for Senti Biosciences, Inc., noting that the company's solutions can address a number of major issues with current gene therapies.
In its most recent earnings report, the company reported revenue of $1.36 million, representing a robust 72% annual growth, and GAAP earnings per share of $0.86. Two million Senti Biosciences, Inc. shares, worth $4.5 million, were added to Ark Investment's investment portfolio during the third quarter.
Two of the 895 hedge funds surveyed by Insider Monkey earlier this year had made investments in the business by the end of the second quarter. No. 3. XPeng Inc. (NYSE: XPEV), Value of Ark Investment's Position: $5.1 million Chinese automaker XPeng Inc. sells a range of automobiles, including sports utility vehicles (SUVs), sports sedans, and family sedans.
The People's Republic of China's Guangzhou serves as the company's headquarters. A key player in China's expanding electric car sector, which witnessed a record 675,000 sales in September 2022, is XPeng Inc. By the end of September, the firm had delivered 98,553 vehicles, a 75% yearly increase over the number of vehicles it had sold for the entire year 2021.
A $5.1 million interest in the business was acquired by Ark Investment during the third quarter of this year. Out of the 895 hedge funds surveyed by Insider Monkey, 24 made investments in XPeng Inc. by the end of the second quarter of this year. The major investor in XPeng Inc. is Tiger Global Management LLC, run by Chase Coleman and Feroz Dewan.
It is the owner of 4.3 million shares, valued at $138 million. No. 2. Moderna, Inc. (NASDAQ: MRNA), Value of Ark Investment's Position: $19 million Using messenger ribonucleic acid technology, American biotechnology company Moderna, Inc. is working to create treatments for cancer, immune system disorders, heart diseases, and infectious diseases.
The business's main office is in Cambridge, Massachusetts. As the third quarter of this year came to a close, Ark Investment had invested $19 million in 163,592 shares of Moderna, Inc., or 0.13% of its total holdings. 45 hedge funds out of 895 surveyed by Insider Monkey in Q2 2022 invested in the company.
Moderna, Inc. not only produces the most sophisticated coronavirus vaccine on the market, but the company is also working with pharmaceutical behemoth Merck to create a cancer vaccine for melanoma patients. The companies anticipate reporting trial results during the current quarter. Patrick Degorce's Theleme Partners is the largest shareholder in Moderna, Inc., holding 6.3 million shares with a market value of $907 million.
No. 1. Guardant Health, Inc. (NASDAQ: GH), Value of Ark Investment's Position: $29 million American medical diagnostics company Guardant Health, Inc. provides services like blood tests, coronavirus screenings, and cancer biopsy examinations. California's Redwood City serves as the company's headquarters.
During the third quarter of this year, Cathie Wood's investment company acquired 542,113 shares of Guardant Health, Inc., giving it a $29 million interest in the business. 35 of the 895 hedge funds surveyed by Insider Monkey in the last quarter made investments in the business. The Guardant360 liquid biopsy test from Guardant Health, Inc.
received FDA approval in August 2022. With the use of Enhertu cancer medicine, this test identifies lung cancer patients who can get treatment. With the FDA clearance opening up more business opportunities, the company generated $400 million in sales in June 2022. Andreas Halvorsen's Viking Global, which owns 4.4 million shares of Guardant Health, Inc.
(NASDAQ: GH) valued at $180 million, is the company with the largest stake. The content in this video is for educational purposes only and hence should not be considered as financial advice. Do conduct your own due diligence and consult your financial advisor before making any investment decisions.
Comments 0